Ubs Asset Management Americas Inc Pulse Biosciences, Inc. Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 48,331 shares of PLSE stock, worth $934,721. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,331
Previous 36,531
32.3%
Holding current value
$934,721
Previous $587,000
24.19%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PLSE
# of Institutions
90Shares Held
5.85MCall Options Held
37.5KPut Options Held
33.6K-
Vanguard Group Inc Valley Forge, PA1.22MShares$23.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.15MShares$22.2 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC784KShares$15.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA499KShares$9.66 Million0.0% of portfolio
-
State Street Corp Boston, MA419KShares$8.11 Million0.0% of portfolio
About Pulse Biosciences, Inc.
- Ticker PLSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,125,900
- Market Cap $718M
- Description
- Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...